We are looking forward to attending Action Duchenne's Annual International Conference this weekend and talking to the community about how we use community insights in our drug development programs.
PepGen
Biotechnology Research
Boston, Massachusetts 9,831 followers
Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.
About us
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
- Website
-
http://pepgen.com
External link for PepGen
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Public Company
- Founded
- 2018
- Specialties
- Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics
Locations
-
Primary
321 Harrison Ave
8th Floor
Boston, Massachusetts 02118, US
Employees at PepGen
Updates
-
Today, we reported our financial results and recent corporate highlights for the third quarter of 2024. You can read our press release here: https://lnkd.in/e4QNqybH
-
Save the dates! PepGen will be participating in two upcoming investor conferences this month: Guggenheim Partners’ Inaugural Healthcare Innovation Conference and the Stifel Financial Corp. 2024 Healthcare Conference. More details: https://lnkd.in/eC9zT_RE
-
Clinical trials can be difficult to navigate if you aren’t familiar with all the terms. That’s why #ProfessorPepGen is here to help you brush up on your clinical trial lingo with “Lesson 3: The Clinical Trial Dictionary.” #PatientEducation #Advocacy #ClinicalTrials
-
October is #MentalHealthAwarenessMonth! Here at PepGen, we hosted a screening of the movie "Brothers" created by Michael Norton which tells the story of his family's #DMD experience and their mental health challenges.
-
Earlier this year, PepGen presented at Myotonic Dystrophy Foundation’s regional conference in Seattle, Washington. Click the link to hear about our #DM1 program updates. https://lnkd.in/eUrh3Hw6
Industry Updates - 2024 MDF Regional Conference in Seattle, WA
https://www.youtube.com/
-
#ICYMI, we released our mid-year advocacy newsletter with updates from Q2 and Q3. Click the link to see the newsletter in English, Spanish, French, or Italian: https://lnkd.in/e_VphdqU
-
Today marks the start of the 29th Annual Congress of the World Muscle Society, and the PepGen team is in Prague getting ready for an exciting week ahead! Find more details on our upcoming presentations here: https://lnkd.in/eDYgSzbF #WMS2024
-
This week, PepGen will be participating in two medical conferences: the 20th Annual Meeting of the Oligonucleotide Therapeutics Society in Montreal and Applied Pharmaceutical Analysis 2024 right here in Boston. If you’ll be in attendance, please come say hello. Otherwise, you can find the posters presented on the Investors page of PepGen’s website under Scientific Publications. Swipe for more details.
-
We are gearing up for a busy next week, as members of the PepGen team are getting ready to go to Prague for the 29th Annual Congress of the World Muscle Society. In addition to several poster presentations, our CMO Michelle Mellion, MD will give a short oral presentation on CONNECT1 data and will be leading a career development session. Following the conference, the presentations will be available on the Investors page of PepGen’s website under Scientific Publications. Swipe for more details. #WMS2024